Merck KGaA suffers major blow as MS drug fails in late-stage trials

[ad_1] [1/2]A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt, Germany January 28, 2016. REUTERS/Ralph Orlowski/File Photo Acquire Licensing Rights FRANKFURT, Dec 5 (Reuters) – Germany’s…

U.S. FTC focuses on deal with Japanese company in Shkreli trial

[ad_1] NEW YORK, Dec 14 (Reuters) – The U.S. Federal Trade Commission on Tuesday kicked off the trial of its civil case against Vyera Pharmaceuticals founder Martin Shkreli, grilling company…